DK0629635T3 - Hidtil ukendte 19-nor-11beta-phenoxysulfonamid- eller 11beta-phenoxysulfonylureasteroider, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf - Google Patents
Hidtil ukendte 19-nor-11beta-phenoxysulfonamid- eller 11beta-phenoxysulfonylureasteroider, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold derafInfo
- Publication number
- DK0629635T3 DK0629635T3 DK94401344.0T DK94401344T DK0629635T3 DK 0629635 T3 DK0629635 T3 DK 0629635T3 DK 94401344 T DK94401344 T DK 94401344T DK 0629635 T3 DK0629635 T3 DK 0629635T3
- Authority
- DK
- Denmark
- Prior art keywords
- radical
- 11beta
- alkyl
- preparation
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9307310A FR2706454B1 (fr) | 1993-06-17 | 1993-06-17 | Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0629635T3 true DK0629635T3 (da) | 1997-09-22 |
Family
ID=9448234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94401344.0T DK0629635T3 (da) | 1993-06-17 | 1994-06-16 | Hidtil ukendte 19-nor-11beta-phenoxysulfonamid- eller 11beta-phenoxysulfonylureasteroider, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf |
Country Status (16)
Country | Link |
---|---|
US (3) | US5494907A (da) |
EP (1) | EP0629635B1 (da) |
JP (1) | JP3621132B2 (da) |
KR (1) | KR100341427B1 (da) |
CN (2) | CN1054856C (da) |
AT (1) | ATE150466T1 (da) |
AU (1) | AU673919B2 (da) |
CA (1) | CA2126158A1 (da) |
DE (1) | DE69402114T2 (da) |
DK (1) | DK0629635T3 (da) |
ES (1) | ES2099551T3 (da) |
FR (1) | FR2706454B1 (da) |
GR (1) | GR3023107T3 (da) |
HU (1) | HUT67308A (da) |
RU (1) | RU2140423C1 (da) |
ZA (1) | ZA943381B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA941464B (en) * | 1993-03-05 | 1994-09-27 | Akzo Nv | Use of pregnane derivative |
US5679788A (en) * | 1993-06-17 | 1997-10-21 | Roussel Uclaf | 11 beta-substituted-19 nor-steroids |
CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
US7009052B2 (en) * | 2003-03-20 | 2006-03-07 | Warner Lambert Company Llc | Sulfonamide derivatives |
WO2005035517A1 (en) * | 2003-10-14 | 2005-04-21 | Council Of Scientific And Industrial Research | (3r, 4r)-trans-3,4-diarylchroman derivatives with estrogenic activity |
WO2006035525A1 (ja) * | 2004-09-29 | 2006-04-06 | Morinaga Milk Industry Co., Ltd. | 高血糖改善のための医薬及び飲食品 |
EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
KR20070063574A (ko) * | 2005-05-17 | 2007-06-19 | 모리나가 뉴교 가부시키가이샤 | 췌장 기능 개선을 위한 의약 또는 음식품 |
EP1882472B1 (en) * | 2005-05-17 | 2018-08-22 | Morinaga Milk Industry Co., Ltd. | Drugs, food or drink for improving pancreatic functions |
GB0511051D0 (en) * | 2005-05-31 | 2005-07-06 | Exxonmobil Chem Patents Inc | Molecular sieve catalyst treatment |
US7312198B2 (en) * | 2005-07-12 | 2007-12-25 | Essential Skincare, Llc | Protein compositions for promoting wound healing and skin regeneration |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
RU2419438C2 (ru) * | 2005-09-22 | 2011-05-27 | Моринага Милк Индастри Ко., Лтд. | Средство для ингибирования накопления висцеральной жировой ткани |
DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
CN114957367B (zh) * | 2022-05-27 | 2023-12-29 | 黄冈人福药业有限责任公司 | 一种生物法制备睾酮的精制方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR384842A (fr) * | 1907-12-09 | 1908-04-23 | Emile Artigue | Plaque photographique auto-retouche |
FR471612A (fr) * | 1913-05-08 | 1914-11-05 | Zeiss Carl Soc | Lentille collectrice devant etre intercalée entre deux systèmes redresseurs dans les instruments destinés à l'inspection des corps creux |
US4978657A (en) * | 1981-01-09 | 1990-12-18 | Roussel Uclaf | Novel 11β-substituted-19-nor-steroids |
FR2528434B1 (fr) * | 1982-06-11 | 1985-07-19 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament |
FR2640977A2 (en) * | 1982-06-11 | 1990-06-29 | Roussel Uclaf | New position-11 substituted 19-norsteroids and their application as medicinal products. |
FR2618783B1 (fr) * | 1987-07-30 | 1991-02-01 | Roussel Uclaf | Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant |
FR2643638B1 (fr) * | 1989-02-24 | 1991-06-14 | Roussel Uclaf | Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
DE69128820T2 (de) * | 1990-08-14 | 1998-06-10 | Hoechst Marion Roussel Inc | Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon |
FR2685332A1 (fr) * | 1991-12-20 | 1993-06-25 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
FR2688004A1 (fr) * | 1992-02-27 | 1993-09-03 | Roussel Uclaf | Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments. |
-
1993
- 1993-06-17 FR FR9307310A patent/FR2706454B1/fr not_active Expired - Fee Related
-
1994
- 1994-05-06 HU HU9401427A patent/HUT67308A/hu unknown
- 1994-05-17 ZA ZA943381A patent/ZA943381B/xx unknown
- 1994-05-19 US US08/246,190 patent/US5494907A/en not_active Expired - Lifetime
- 1994-06-16 ES ES94401344T patent/ES2099551T3/es not_active Expired - Lifetime
- 1994-06-16 EP EP94401344A patent/EP0629635B1/fr not_active Expired - Lifetime
- 1994-06-16 DK DK94401344.0T patent/DK0629635T3/da active
- 1994-06-16 DE DE69402114T patent/DE69402114T2/de not_active Expired - Lifetime
- 1994-06-16 KR KR1019940013594A patent/KR100341427B1/ko not_active IP Right Cessation
- 1994-06-16 AT AT94401344T patent/ATE150466T1/de not_active IP Right Cessation
- 1994-06-16 CN CN94106469A patent/CN1054856C/zh not_active Expired - Fee Related
- 1994-06-16 JP JP15640794A patent/JP3621132B2/ja not_active Expired - Fee Related
- 1994-06-16 RU RU94022277A patent/RU2140423C1/ru not_active IP Right Cessation
- 1994-06-17 CA CA002126158A patent/CA2126158A1/fr not_active Abandoned
- 1994-06-17 AU AU64763/94A patent/AU673919B2/en not_active Ceased
-
1995
- 1995-05-19 US US08/445,385 patent/US5556845A/en not_active Expired - Lifetime
- 1995-08-08 US US08/512,284 patent/US5705494A/en not_active Expired - Lifetime
-
1997
- 1997-04-11 GR GR960402896T patent/GR3023107T3/el unknown
-
1998
- 1998-05-09 CN CN98108945A patent/CN1271734A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2706454A1 (fr) | 1994-12-23 |
FR2706454B1 (fr) | 1995-09-15 |
AU6476394A (en) | 1994-12-22 |
CA2126158A1 (fr) | 1994-12-18 |
RU94022277A (ru) | 1996-04-20 |
CN1101915A (zh) | 1995-04-26 |
CN1271734A (zh) | 2000-11-01 |
US5556845A (en) | 1996-09-17 |
EP0629635B1 (fr) | 1997-03-19 |
ES2099551T3 (es) | 1997-05-16 |
HUT67308A (en) | 1995-03-28 |
US5494907A (en) | 1996-02-27 |
JPH0717996A (ja) | 1995-01-20 |
EP0629635A1 (fr) | 1994-12-21 |
DE69402114T2 (de) | 1997-09-11 |
ZA943381B (en) | 1995-05-17 |
CN1054856C (zh) | 2000-07-26 |
JP3621132B2 (ja) | 2005-02-16 |
KR950000729A (ko) | 1995-01-03 |
HU9401427D0 (en) | 1994-08-29 |
US5705494A (en) | 1998-01-06 |
RU2140423C1 (ru) | 1999-10-27 |
KR100341427B1 (ko) | 2002-11-14 |
ATE150466T1 (de) | 1997-04-15 |
GR3023107T3 (en) | 1997-07-30 |
AU673919B2 (en) | 1996-11-28 |
DE69402114D1 (de) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0629635T3 (da) | Hidtil ukendte 19-nor-11beta-phenoxysulfonamid- eller 11beta-phenoxysulfonylureasteroider, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
DK163120C (da) | Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf | |
ATE52498T1 (de) | Amidderivate. | |
NZ238181A (en) | N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions | |
NO162284C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive spiro(4. (3+n))-2-aza-alkan-3-karboksylsyre-derivater. | |
NO167141C (no) | Bicykliske aromatiske forbindelser for kosmetisk anvendelse og blandinger som inneholder dem. | |
DK0412404T3 (da) | Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne | |
BR1100931A (pt) | Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis | |
DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
ATE153666T1 (de) | Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung | |
DK0465369T3 (da) | N-substituerede derivater af alpha-mercaptoalkylaminer, deres fremstilling og anvendelse som lægemidler, farmaceutiske præparater med indhold deraf samt mellemprodukter | |
DK0437128T3 (da) | Anvendelse af et fluorquinolonderivat til fremstilling af et lægemiddel til behandling af pneumocystosis | |
DK0437120T3 (da) | Pyridonderivater, deres fremstilling og anvendelse som lægemidler samt farmaceutiske præparater med indhold heraf og hidtil ukendte mellemprodukter | |
FI833453A0 (fi) | Terapeutiska medel | |
DK0541407T3 (da) | Nitrogenholdige, bicykliske derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem | |
DK0395528T3 (da) | 4-phenylmethyl-1H-indolderivater, en fremgangsmåde til og mellemprodukter ved deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf | |
MX9203712A (es) | Derivados de benzanilida y composiciones farmaceuticas que los contienen. | |
ES491915A0 (es) | Procedimiento para la preparacion de derivados de xantina | |
PT83975B (pt) | Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem | |
ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
PE20030438A1 (es) | Medicamento que comprende un derivado de eritromicina como agente antituberculoso | |
TH13838EX (th) | สิ่งเคลือบบนกระจก | |
ATE87004T1 (de) | Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln. |